664 related articles for article (PubMed ID: 30914502)
1. A Klebsiella pneumoniae Regulatory Mutant Has Reduced Capsule Expression but Retains Hypermucoviscosity.
Walker KA; Miner TA; Palacios M; Trzilova D; Frederick DR; Broberg CA; Sepúlveda VE; Quinn JD; Miller VL
mBio; 2019 Mar; 10(2):. PubMed ID: 30914502
[TBL] [Abstract][Full Text] [Related]
2. The Small Protein RmpD Drives Hypermucoviscosity in Klebsiella pneumoniae.
Walker KA; Treat LP; Sepúlveda VE; Miller VL
mBio; 2020 Sep; 11(5):. PubMed ID: 32963003
[No Abstract] [Full Text] [Related]
3. Identification of Two Regulators of Virulence That Are Conserved in
Palacios M; Miner TA; Frederick DR; Sepulveda VE; Quinn JD; Walker KA; Miller VL
mBio; 2018 Aug; 9(4):. PubMed ID: 30087173
[No Abstract] [Full Text] [Related]
4. Functional Characterization of Plasmid-Borne
Yang X; Liu X; Chan EW; Zhang R; Chen S
Microbiol Spectr; 2023 Jun; 11(3):e0308122. PubMed ID: 37092989
[TBL] [Abstract][Full Text] [Related]
5. Unusual Hypermucoviscous Clinical Isolate of Klebsiella pneumoniae with No Known Determinants of Hypermucoviscosity.
Dey T; Chakrabortty A; Kapoor A; Warrier A; Nag VL; Sivashanmugam K; Shankar M
Microbiol Spectr; 2022 Jun; 10(3):e0039322. PubMed ID: 35647656
[TBL] [Abstract][Full Text] [Related]
6. Hypermucoviscosity Regulator RmpD Interacts with Wzc and Controls Capsular Polysaccharide Chain Length.
Ovchinnikova OG; Treat LP; Teelucksingh T; Clarke BR; Miner TA; Whitfield C; Walker KA; Miller VL
mBio; 2023 Jun; 14(3):e0080023. PubMed ID: 37140436
[TBL] [Abstract][Full Text] [Related]
7. Adaptive attenuation of virulence in hypervirulent carbapenem-resistant
Teng G; Zhang M; Fu Y; Yang X; Kang Y; Qin Q; Jin Y; Huang M; Xu Y
mSystems; 2024 Jun; 9(6):e0136323. PubMed ID: 38752758
[TBL] [Abstract][Full Text] [Related]
8. The Capsule Regulatory Network of
Dorman MJ; Feltwell T; Goulding DA; Parkhill J; Short FL
mBio; 2018 Nov; 9(6):. PubMed ID: 30459193
[No Abstract] [Full Text] [Related]
9. The intersection of capsule gene expression, hypermucoviscosity and hypervirulence in Klebsiella pneumoniae.
Walker KA; Miller VL
Curr Opin Microbiol; 2020 Apr; 54():95-102. PubMed ID: 32062153
[TBL] [Abstract][Full Text] [Related]
10. A systematic analysis of hypermucoviscosity and capsule reveals distinct and overlapping genes that impact Klebsiella pneumoniae fitness.
Mike LA; Stark AJ; Forsyth VS; Vornhagen J; Smith SN; Bachman MA; Mobley HLT
PLoS Pathog; 2021 Mar; 17(3):e1009376. PubMed ID: 33720976
[TBL] [Abstract][Full Text] [Related]
11. The role of Klebsiella pneumoniae rmpA in capsular polysaccharide synthesis and virulence revisited.
Hsu CR; Lin TL; Chen YC; Chou HC; Wang JT
Microbiology (Reading); 2011 Dec; 157(Pt 12):3446-3457. PubMed ID: 21964731
[TBL] [Abstract][Full Text] [Related]
12. Cell envelope defects of different capsule-null mutants in K1 hypervirulent Klebsiella pneumoniae can affect bacterial pathogenesis.
Tan YH; Chen Y; Chu WHW; Sham LT; Gan YH
Mol Microbiol; 2020 May; 113(5):889-905. PubMed ID: 31912541
[TBL] [Abstract][Full Text] [Related]
13. Low prevalence of rmpA and high tendency of rmpA mutation correspond to low virulence of extended spectrum β-lactamase-producing Klebsiella pneumoniae isolates.
Yu WL; Lee MF; Tang HJ; Chang MC; Chuang YC
Virulence; 2015; 6(2):162-72. PubMed ID: 25830726
[TBL] [Abstract][Full Text] [Related]
14. Different regulatory mechanisms of the capsule in hypervirulent
Wang W; Tian D; Hu D; Chen W; Zhou Y; Jiang X
Front Cell Infect Microbiol; 2023; 13():1108818. PubMed ID: 37180440
[TBL] [Abstract][Full Text] [Related]
15. RmpA regulation of capsular polysaccharide biosynthesis in Klebsiella pneumoniae CG43.
Cheng HY; Chen YS; Wu CY; Chang HY; Lai YC; Peng HL
J Bacteriol; 2010 Jun; 192(12):3144-58. PubMed ID: 20382770
[TBL] [Abstract][Full Text] [Related]
16. Urine-mediated suppression of
Khadka S; Ring BE; Walker RS; Krzeminski LR; Pariseau DA; Hathaway M; Mobley HLT; Mike LA
mSphere; 2023 Oct; 8(5):e0028823. PubMed ID: 37610214
[No Abstract] [Full Text] [Related]
17. Discovery of anti-mucoviscous activity of rifampicin and its potential as a candidate antivirulence agent against hypervirulent Klebsiella pneumoniae.
Namikawa H; Oinuma KI; Sakiyama A; Tsubouchi T; Tahara YO; Yamada K; Niki M; Takemoto Y; Miyata M; Kaneko Y; Shuto T; Kakeya H
Int J Antimicrob Agents; 2019 Aug; 54(2):167-175. PubMed ID: 31173862
[TBL] [Abstract][Full Text] [Related]
18. Association between rmpA and magA genes and clinical syndromes caused by Klebsiella pneumoniae in Taiwan.
Yu WL; Ko WC; Cheng KC; Lee HC; Ke DS; Lee CC; Fung CP; Chuang YC
Clin Infect Dis; 2006 May; 42(10):1351-8. PubMed ID: 16619144
[TBL] [Abstract][Full Text] [Related]
19. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed.
Shon AS; Bajwa RP; Russo TA
Virulence; 2013 Feb; 4(2):107-18. PubMed ID: 23302790
[TBL] [Abstract][Full Text] [Related]
20. First two cases of severe multifocal infections caused by Klebsiella pneumoniae in Switzerland: characterization of an atypical non-K1/K2-serotype strain causing liver abscess and endocarditis.
Babouee Flury B; Donà V; Buetti N; Furrer H; Endimiani A
J Glob Antimicrob Resist; 2017 Sep; 10():165-170. PubMed ID: 28729207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
